發(fā)布時間：2018-08-23 09:24

【摘要】：根據(jù)時下較為流行的低成本國家采購概念，這篇論文主要從醫(yī)藥行業(yè)G公司一些被挑選的、真實的低成本國家采購項目出發(fā)，結(jié)合相關(guān)供應(yīng)鏈管理理論工具，以及G公司現(xiàn)行的一些方法工具進行推敲對比，并提出更為優(yōu)化的改進方案。 第一章節(jié)中的背景研究主要分為二個部分。一是中國醫(yī)藥行業(yè)無論從整個行業(yè)總產(chǎn)值，還是行業(yè)利潤率，或者是外資、合資企業(yè)持續(xù)投資三個方面來看都是向上趨勢。二是從幾個熱門低成本國家的綜合實力的比較中得出中國具有較高的優(yōu)勢。其次，介紹了本文的研究意義以及思路。 第二章節(jié)的理論綜述中明確對低成本國家采購的定義及相關(guān)優(yōu)勢。不得不提的是在執(zhí)行低成本國家采購項目時可能碰到的風(fēng)險和相應(yīng)解決方案以及工具。其中著重介紹了以二維象限法為理論基礎(chǔ)的供應(yīng)商分類法，以關(guān)鍵績效指標法為理論基礎(chǔ)的供應(yīng)商質(zhì)量管理法，以及總擁有成本（TCO）等等對低成本國家采購有著直接影響的理論工具。 第三章節(jié)就G公司的實際情況介紹分析了實際低成本國家采購執(zhí)行中所碰到的問題。 第四章節(jié)針對第三章中提出的問題進行了分析建議，提出合理化改進方案。 第五章節(jié)對目前碰到問題以外潛在存在的問題，尤其是對將來會對可持續(xù)發(fā)展造成瓶頸的問題進行了提煉總結(jié)。 第六章節(jié)對以上五個章節(jié)做了大致的概括總結(jié)。 全文立足于中國醫(yī)藥行業(yè)大環(huán)境下，，針對G公司實際執(zhí)行的低成本國家采購項目所產(chǎn)生的問題，具體問題具體分析，最終提出優(yōu)化方案。因為論文研究時間較短，有部分不夠深入的地方已在第五章所提出的一些潛在挑戰(zhàn)中進行概括，仍然需要今后在實際工作中更多地研究分析和驗證。
[Abstract]:According to the current popular concept of low-cost country procurement, this paper mainly starts from some selected and real low-cost country procurement projects in pharmaceutical industry company G, combining with relevant supply chain management theory tools. And some existing methods and tools of G Company are compared, and a more optimized improvement scheme is put forward. The background research in the first chapter is divided into two parts. One is that the Chinese pharmaceutical industry is an upward trend in terms of the total output value of the whole industry, the profit margin of the industry, or foreign investment, and the sustained investment of the joint venture. Second, from the comparison of the comprehensive strength of several popular low-cost countries, China has a higher advantage. Secondly, this paper introduces the significance of the research and ideas. The second chapter makes clear the definition of low-cost country procurement and its relative advantages. Mention must be made of the risks and solutions and tools involved in the implementation of low-cost country procurement projects. The supplier classification method based on the two-dimensional quadrant method and the supplier quality management method based on the key performance index method are introduced. And total cost of ownership (TCO) and other theoretical tools that have a direct impact on low-cost country procurement. The third chapter introduces the actual situation of company G and analyzes the problems encountered in the actual low-cost country procurement execution. The fourth chapter analyzes the problems in the third chapter and puts forward the rationalization scheme. The fifth chapter summarizes the potential problems beyond the current problems, especially the problems that will lead to the bottleneck of sustainable development in the future. The sixth chapter makes a general summary of the above five chapters. This paper is based on the Chinese pharmaceutical industry environment, aiming at the problems caused by the low cost national procurement projects actually carried out by company G, the specific problems are analyzed, and the optimization scheme is finally put forward. Because the research time of the thesis is short and some parts of the research have been summarized in some potential challenges raised in Chapter 5, more research, analysis and verification are still needed in practical work in the future.
【學(xué)位授予單位】：上海外國語大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2014
【分類號】：F274;F426.72

【參考文獻】

相關(guān)期刊論文 前1條

1 趙崎;;低成本國家采購對中國供應(yīng)商的挑戰(zhàn)[J];國際市場;2006年10期

本文編號：2198613